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Abstract
Background: Milk is an important source of nutrients. The consumption of milk, however, may cause abdominal
complaints in lactose intolerant individuals. The frequency of -13910C/C genotype is known to be high among
Northern Russians, exceeding the prevalence in northern Europe. In our study we tested two hypotheses: 1)
subjects with lactase non-persistent genotype (-13910C/C) have more gastrointestinal (GI) symptoms associated
with milk 2) subjects with lactase non-persistence avoid using milk.
Methods: In total, 518 students aged 17 to 26 years were randomly selected from different departments in the
Northern State Medical University (NSMU) for genotyping the lactase activity-defining -13910C/T variant. All
subjects filled in a questionnaire covering their personal data, self-reported GI symptoms and milk consumption
habits.
Results: Northern Russians consume very small amounts of milk daily. Among carriers of the lactase non-persistent
(LNP) genotype there were 10 percentage units of milk-consumers fewer than among lactase-persistent (LP)
subjects (p = 0.03). Complaints of GI disorders caused by milk were different between the genotypes (p = 0.02).
Among all types of food analyzed only milk was associated with increased GI symptoms among subjects with the
LNP genotype (OR = 1.95, CI 1.03-3.69)
Conclusions: Subjects with -13910C/C have more GI symptoms from milk. Subjects with lactase non-persistent
genotype avoid using milk. In the case of increasing milk consumption symptoms may increase the need for
medical consultation. It is thus important either for people themselves or for health care staff to be aware of
lactase persistence/non-persistence.
Background
Milk is an important source of everyday nutrition.
Bovine milk is a rich resource of nutrients containing
lipids, proteins, amino acids, vitamins and minerals.
Such substances as immunoglobulins, hormones, growth
factors, cytokines, nucleotides, peptides, polyamines,
enzymes and other bioactive peptides are also present in
milk [1,2]. Milk has been considered a major source of
calcium as well as the simplest and most “cost-effective”
way to ingest calcium [3,4]. In that dairy products also
provide other important nutrients, their consumption
improves the nutritional quality of the diet appreciably
[4,5].
This notwithstanding, the consumption of milk has
decreased over the last decade in Northern Europe [1,5].
Data on milk consumption in Russia in recent years
have been very limited and available only from market
analyses, which show a decrease in milk consumption in
some regions of country [6]. Consumption is low among
young Northern Russians [7]. The above-mentioned
properties of milk make it important for everyday nutri-
tion, especially for children. Recently a national pro-
gram, “School milk”, aimed to supply schoolchildren
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mented in Russia [8].
Adult-type hypolactasia, characterized by the down-
regulation of lactase enzyme activity in the intestine
during human growth, is inherited as an autosomal
recessive trait [9,10]. The first genetic variant associated
with adult-type hypolactasia, a one-base polymorphism
C > T -13910 (rs 4988234) upstream of the lactase
encoding gene on chromosome 2, was identified in 2002
[11]. This -13910 C/T is the most common variant of
lactase persistence among Caucasians [12]. Several other
population-specific variants nearby have been identified,
some of them only suggestive [13-16]. The -13910C/T
has been shown to be located in the OCT-1 binding site
and acts as an enhancer. Nowadays the genotyping can
be used as the test for adult-type hypolactasia with
100% specificity in cases of unspecific abdominal com-
plaints [17,18].
Milk contains disaccharide lactose, which may cause
gastrointestinal problems in adults by reason of its poor
digestion in part of population. In Northern Europe lac-
tase persistence is common, which allows the majority
of the population to drink milk without any conse-
quences [19]. However, in populations where the fre-
quency of the lactase persistent genotype is rather low
the consumption of milk may cause complaints in the
digestive tract [20]. The development of symptoms
depends on the amount of milk consumed as well as on
individual sensitivity. It has been shown that subjects
with hypolactasia can tolerate moderate quantities of
milk, up to 12 g of lactose/200 ml of milk. If the daily
dose of lactose is consumed in small portions and also
with a meal, the likelihood of symptoms is low [20-22].
The most common gastrointestinal (GI) symptoms
which characterize intolerance to lactose are flatulence,
diarrhea, gurgling, abdominal distension and abdominal
cramping [22-24]. The appearance of symptoms is
clearly explained by mechanism of lactose utilization.
Lactase-phlorizin hydrolase splits the entering lactose
into two monosaccharides, glucose and galactose. The
lack of lactase activity leads to intake of indigested lac-
tose into the bowel. The osmotic effect causes diarrhea
[25], while an increased level of fermentation in the
intestine leads to increasing production of gases and
thus to flatulence [26,27].
The prevalence of adult-type hypolactasia (lactase non-
persistence, -13910C/C) among Northern Russians has
been found to be 35% [7]. It has also been shown that the
prevalence of the -13910C/C genotype among Russians
living in the central part of the country ranges from 36 to
50% [28,29]. This frequency is twice as high as in Finland
and many times higher compared with other Scandina-
vian countries [30-33]. It also exceeds the prevalence of
the -13910C/C genotype among Estonians [34].
Recent studies have shown that subjects with intoler-
ance to lactose tend to reduce their consumption of
milk, which is predictable as far as they suffer from
symptoms after milk consumption [31,35-38]. In our
previous study [7] subjects showed no differences
between genotypes in the frequency of GI complaints
during life. We found, however, that the consumption of
milk is extremely low among the Northern Russian
population compared with other Northern populations.
Does milk consumption influence the appearance of GI
symptoms in a population with a high frequency of the
lactase non-persistent genotype but with very low con-
sumption of milk on the whole?
In the present study we sought to test two hypotheses:
1) subjects with lactase non-persistent genotype
(-13910C/C) possibly have more gastrointestinal symp-
toms associated with milk 2) subjects with lactase non-
persistence avoid using milk.
Methods
Study population
Students aged 17 to 26 years were randomly selected for
this investigation from different departments in the
Northern State Medical University (NSMU) during the
period from 2006 to 2008. Blood samples (n = 241) or
buccal samples (n = 277) were taken from 518 subjects
in total for the genotyping of the lactase activity-defin-
ing -13910 C/T variant.
The first group were recruited during the period 2006-
2007 and blood samples were drawn for the genotyping.
The second group were recruited during the period
2007-2008 and buccal samples were taken for the same
purpose. The mean age for whole group was 19.8 ±
1.72. Women represented 78.2% of all participants. Both
groups of students were similar with respect to distribu-
tions of age and gender.
For randomization we used the official list of students
of the NSMU. Since there are 16 faculties in the Univer-
sity and each has 10 to 12 groups of students we took
for our study every third group from every fourth
faculty.
The study was approved by the Ethics Committee of
the NSMU (No 08/06 from 29.11.2006). All subjects
gave their informed consent to participate.
Analyses of genotype
Blood samples were genotyped at the Department of
Medical Genetics, University of Helsinki. Buccal samples
were genotyped at the Forensic Laboratory in the Uni-
versity of Tampere.
Genotyping of blood samples was performed as pre-
viously described [11]. DNA was amplified by polymer-
ase chain reaction (PCR). We used Taq polymerase
(Dynazyme, Finnzymes, Espoo, Finland) with the
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used was 5’-CCTCGTTAATACCCACTGACCTA-3’ and
the reverse primer was 5’-GTCACTTTGATATGATGA-
GAGCA-3’, which cover about 400 bp regions on both
sides of the C/T-13910 variant. The PCR product was
verified by 1.5% agarose gel electrophoresis (with ethi-
dium bromide). The PCR products were purified using
Shrimp Alkaline Phosphatase (USB) and Exonuclease I
(New England Biolabs) at 37°C for 60 min and at 80°C
for 15 min.
In sequencing, a BigDye 3.1 terminator (Applied Bio-
systems) was used according to the manufacturer’s
instructions. Sequencing conditions were as follows: at
96°C for 1 min, then 25 cycles at 96°C for 10 s, at 55°C
for 5 s and at 60°C for 4 min. The sequencing reaction
followed purification on Millipore Multiscreen plates
(Millipore, USA) with Sephadex G-50 Superfine sephar-
ose (Amersham Biosciences, Sweden), electrophoresis by
ABI 3730 DNA Analyzer (Applied Biosystems) and base
calling by Sequencing Analysis 5.2 software (Applied
Biosystems). The sequence obtained was analyzed using
Sequencher 4.6. software (Gene Codes, USA).
The polymorphism of lactase persistence/non-persis-
tence SNP rs4988235 from buccal samples was deter-
mined by TaqMan Human Custom Genotyping Assay
from Applied Biosystems. The assay was performed
according to the instructions provided with the assay
with an ABI Prism 7900 HT sequence detection system
(AppliedBiosystems, California, USA).
Questionnaire
All subjects gave written informed consent and filled in
a questionnaire covering their personal data, self-
reported condition of health, GI symptoms and milk
consumption habits. We used the questionnaire with
permission from Sahi [10].
Gastrointestinal symptoms were estimated by the
question “Have you ever experienced the following
symptoms and in what frequency?” The question was
not intended to clarify the connection between milk
consumption and symptoms. The various answers were
“Every day”, “At least once per week”, “Every second
week”, “Sometimes”. If the participant had never had the
symptom the item was left blank. We classified the
answer “Sometimes” together with no symptoms into
one group and marked it “Without GI symptoms”.T h e
second group included the remaining variables and was
taken for analyses of differences between genotypes.
The influence of food on the appearance of GI disor-
ders was estimated by the question “Do you have any
GI disorders if you consume the following types of
food?” where six types of food being included. Subjects
were asked to put “Yes” or “No” opposite every type of
food.
In the last part of the questionnaire subjects were
asked to define their everyday milk product consump-
tion from 0 to more than 5 glasses per day. The choices
were “Not at all”, “1-2 glasses”, “3-5 glasses” and “More
than 5 glasses” of milk/sour milk per day. There was
also an option to declare consumption less than 1-2
g l a s s e sp e rd a yf o rt h o s ew h oc o n s u m e dm i l kv e r y
rarely. For the analysis we classified all answers into two
groups: less than daily milk consumption or none and
daily milk consumption.
Comparison was made between the lactase non-persis-
tent group (-13910C/C) and the lactase persistent group
(-13910C/T and -13910 T/T) for all the above-men-
tioned questions.
Statistical analysis
The difference between genotype groups in milk con-
sumption and others were tested by c2 test. Odds ratios
(OR) with 95% confidence interval (CI) for -13910C/C
genotype in the logistic regression analysis were calcu-
lated for gastrointestinal symptoms in total and symp-
toms after several types of food, and for volume of milk/
sour milk consumption. Statistical analyses were per-
formed with SPSS version 15.0 (SPSS Inc. Chicago, IL,
USA).
Results
The prevalence of the -13910C/C genotype (lactase non-
persistence, LNP) among 518 young students from
North-West Russia was found to be 35% (n = 180)
while the -13910C/T genotype was found in 46% and
-13910T/T in 19% of participants.
About sixty percent of all subjects reported GI symp-
toms (Table 1). The most frequent symptom was sto-
mach-ache. However, no statistically significant
Table 1 The frequency of gastrointestinal symptoms (GI)
among young people with lactase-persistent/non-
persistent genotype (Question “Have you ever
experienced the following symptoms?”)
Lactase non-
persistence
C/C-13910
(n = 180)
Lactase
persistence
C/T and T/T-
13910
(n = 338)
GI symptoms n % n % p
Stomach-ache 93 51.7 176 51.9 1.00
Regurgitation 23 12.8 42 12.4 0.89
Flatulence 17 9.4 38 11.2 0.65
Heartburn 14 7.8 23 6.8 0.72
Nausea 13 7.2 25 7.4 1.00
Diarrhea 3 1.7 12 3.5 0.28
Without GI symptoms 74 41.1 142 42.2 0.71
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testinal symptoms in total between the LP and LNP
genotype groups. The study brought out no statistically
significant differences in symptom appearance between
male and female participants.
T h em a j o r i t yo fs u b j e c t sc o n s u m e dv e r ys m a l l
amounts of milk daily. Only about 40% of all partici-
pants used milk every day. Almost 50% did not use milk
at all and 13% reported consumption of milk more sel-
dom than daily (Table 2). Among carriers of the LNP
genotype there were 10 percentage units fewer milk-
consumers in comparison with the LP group (32.2 and
42.0%). The differences were statistically significant (p =
0.03). Sour milk consumption did not show significant
differences in symptoms between LP and LNP subjects.
Milk consumption was associated with GI disorders in
13.3% of subjects with the LNP genotype and in 7.1% of
subjects with the LP genotype (Table 3). Complaints of
GI disorders caused by milk consumption were different
between the genotypes (p = 0.02).
Among all types of food analyzed only milk resulted in
statistically significant differences in symptoms between
LP and LNP subjects (OR = 1.95, CI 1.03-3.69) (Table
4). In regression analysis there was no connection
between consuming food and the appearance of symp-
toms except in milk consumption.
Discussion
Young Northern Russians consume very small amounts
of milk daily. However, among LNP genotype carriers
there are even less milk-consumers than among LP sub-
jects. Our findings demonstrate that milk is the only
type of food having an influence upon the appearance of
GI disorders differently by genotype. We may conclude
that subjects with lactase non-persistence (-13910C/C)
have more symptoms from milk. Subjects with lactase
non-persistent genotype avoid using milk.
Sour milk consumption brought out no differences
between the genotypes. This is in accord with the pre-
vious proved finding that sour milk is better tolerated
than milk by persons with lactose intolerance [21,39].
Sour milk contains less lactose as a result of bacterial
fermentation.
All students recruited for this study were considered
healthy. However, only forty per cent of them did not
report any GI symptoms and half of them reported sto-
mach-ache, which was the most frequent symptom
among all subjects without links to genotype. Possibly
this finding requires further investigation of student
health to clarify the causes of the frequent GI disorders
among a healthy young population.
Table 2 Milk consumption by genotype
Consumption
of milk
Lactase non-
persistence
-13910C/C
(n = 180)
Lactase persistence
-13910C/T and
-13910T/T
(n = 338)
n%n %
Less than daily or none 122 67.8 196 58.0
Daily 58 32.2 142 42.0
Total 180 100 338 100
Table 3 The frequency of GI disorders connected to
different food stuffs (Question “Do you have any GI
disorders if you consume the following types of food?”)
Type of food Lactase non-
persistence
-13910C/C
(n = 180)
Lactase persistence
-13910C/T and
-13910T/T
(n = 338)
p
n% n %
Fatty 56 31.1 120 35.5 0.33
Fried 43 23.9 69 20.4 0.37
Milk 24 13.3 24 7.1 0.02
Sour milk and kefir 16 8.9 17 5.0 0.09
Vegetables 10 5.6 14 4.1 0.51
Fruits 7 3.9 19 5.6 0.53
Any other food 28 15.6 52 15.4 1.00
Not any food 88 47.6 174 51.6 0.74
Table 4 Odds ratios (OR, 95% CI) of the lactase non-
persistent genotype (-13910C/C) in the logistic regression
analysis for gastrointestinal symptoms, symptoms after
some food and milk consumption.
GI symptoms OR
(95% CI)
Diarrhea 2.12 (0.58 - 7.76)
Flatulence 1.17 (0.62 - 2.21)
Nausea 1.04 (0.50 - 2.14)
Stomach pain 1.00 (0.68 - 1.46)
Regurgitation 0.98 (0.53 - 1.76)
Heartburn 0.82 (0.39 - 1.71)
Symptoms after some food
Milk 1.95 (1.03 - 3.69)
Sour milk and kefir 1.61 (0.75 - 3.43)
Fried 1.61 (0.97 - 2.67)
Vegetables 1.25 (0.52 - 3.00)
Any other food 1.02 (0.59 - 1.75)
Fatty 0.68 (0.43 - 1.07)
Fruits 0.52 (0.20 - 1.31)
Milk product consumption
Milk 1.51 (1.04 - 2.17)
Sour milk 1.10 (0.76 - 1.60)
Statistically significant differences are presented in bold face.
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flatulence occurs significantly more frequently among
LNP subjects [39,40]. Jussila and associates [41] showed
that loose stool was a more frequent symptom in sub-
jects with selective lactose malabsorption.
The northern Russians use very small amount of milk
daily. However LNP subjects use less milk than people
with LP genotype. Such a self-prescribed reduction is in
agreement with a study in Finnish children with the
-13910C/C genotype, who naturally diminished their
usage of milk [31] and also with a study in children of
other ethnicities [42]. It was also shown that other age
groups also tend to reduce their milk consumption
because of the appearance of symptoms after milk
[24,38].
It is possible to assume that the low rate of symptoms
was partly related to the low milk intake in our study
population. It is likely even if the prevalence of adult
type hypolactasia in the study population is as much as
35% and low milk consumption is reported symptoms
appear less probably than in other populations. Another
explanation for the low rate of symptoms may be the
age of lactase activity down-regulation. Since there are
no studies estimating the age of decline of enzymatic
activity in Russians there is a slight possibility that this
group was too young to demonstrate differences in GI
disorders.
Vast majority of our randomly selected students were
from North-West Russia [7]. Based on the farming his-
tory, this area was determined in Soviet Union as milk
production area. The region has still been considered as
one of the country’s milk and meat production areas.
The gene-culture co-evolution between cattle milk
genes and humans lactose tolerance has been verified
for North Central Europe [43] and it seems to be also in
north-western part of Russia.
Since milk is an important source of nutrients there
are numerous studies aimed to demonstrate the advan-
tages and disadvantages to milk restriction or elimina-
tion from the diet. The lack of milk in nutrition in the
young population is strongly associated with decreased
bone mineral density and leads to osteoporosis in older
a g e[ 4 2 ] .P r e c i s es t a t i s t i cd a t ao fp r e v a l e n c eo fo s t e o -
porosis among the Russian population are lacking. How-
ever, it is obvious that osteoporosis as well as a higher
risk of bone fractures connected with it is an actual pro-
blem for Russia [44]. Building peak bone mass during
childhood and adolescent can be the best means of pre-
venting osteoporosis in older age.
Conclusions
It is surely warranted to increase milk consumption
among the Russian population by providing a federal
program. The benefits from an increase in milk
c o n s u m p t i o na r eo b v i o u s .A tt h es a m et i m eo u rs t u d y
has shown that lactase non-persistent subjects have
higher frequency of GI disorders even in population
with very small amount of milk consumed. It may be
predicted that in the case of increasing milk consump-
tion symptoms may appear more frequently and may
increase the need for medical consultation and care. It
is therefore important either for people themselves or
for health care staff to be alert to lactase persistence/
non-persistence.
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